| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 272, Issue 6 1391-G1399, Copyright © 1997 by American Physiological Society
ARTICLES |
K. S. Murthy, J. G. Jin, J. R. Grider and G. M. Makhlouf
Department of Physiology, Medical College of Virginia, Richmond 23298, USA.
Pituitary adenylate cyclase-activating peptide (PACAP) receptors and their signaling pathways were characterized in dispersed rabbit gastric muscle cells. 125I-PACAP-27 and 125I-vasoactive intestinal peptide (VIP) binding to muscle cells were inhibited equally by PACAP and VIP (mean inhibitory concentration 0.8 to 1.3 nM) and desensitized to the same extent (70-80%) by exposure to either peptide. PACAP, like VIP, increased cytosolic free Ca2+ and the formation of L-[3H]citrulline, NO-3/NO-2, guanosine 3',5'-cyclic monophosphate (cGMP), and adenosine 3'5'-cyclic monophosphate (cAMP) and induced relaxation (mean effective concentration 1.8 +/- 0.1 nM) that was partly inhibited by NG-nitro-L-arginine (L-NNA), VIP-(10-28), and PACAP 6-38. L-[3H]citrulline and cGMP formation were blocked by nifedipine, L-NNA, and pertussis toxin (PTx), implying activation of a G protein-coupled, Ca(2+)-calmodulin-dependent nitric oxide (NO) synthase. PACAP-induced relaxation was inhibited to the same extent (46-49%) by nifedipine, L-NNA, PTx, and the protein kinase G inhibitor KT-5823; the inhibition reflected the component of relaxation mediated by the NO-cGMP pathway. The residual relaxation was abolished by the protein kinase A inhibitor H-89. The pattern of inhibition of all responses was identical to that observed with VIP. Desensitization with VIP or PACAP abolished cAMP formation but had no effect on L-[3H]citrulline and cGMP formation induced by either peptide. Receptor protection with VIP or PACAP preserved fully all responses (L-[3H]citrulline, cGMP, and cAMP formation and relaxation) to either peptide. The complete cross-competition, cross-desensitization, cross-antagonism, and cross-protection of receptors by either VIP or PACAP are consistent with interaction of both peptides with the same receptors; the receptors consist of two classes, each coupled to a distinct signaling pathway.
This article has been cited by other articles:
|
|
 |
|
  K. S. Murthy, S. Mahavadi, J. Huang, H. Zhou, and W. Sriwai Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle Am J Physiol Cell Physiol, February 1, 2008; 294(2): C477 - C487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, S. Mahavadi, W. Sriwai, J. R. Grider, and K. S. Murthy Cross-regulation of VPAC2 receptor desensitization by M3 receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2 Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G867 - G874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou, J. Huang, and K. S. Murthy Molecular cloning and functional expression of a VIP-specific receptor. Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G728 - G734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-Q. Teng, J. R. Grider, and K. S. Murthy Identification of a VIP-specific receptor in guinea pig tenia coli Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G718 - G725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Z. Shi and S. K. Sarna Impairment of Ca2+ mobilization in circular muscle cells of the inflamed colon Am J Physiol Gastrointest Liver Physiol, February 1, 2000; 278(2): G234 - G242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-A. E. T. Fox-Threlkeld, T. J. McDonald, Z. Woskowska, K. Iesaki, and E. E. Daniel Pituitary Adenylate Cyclase-Activating Peptide as a Neurotransmitter in the Canine Ileal Circular Muscle J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 66 - 75. [Abstract] [Full Text]
|
|
|
|
|
|
G. Van Assche, I. Depoortere, R. De Vos, K. Geboes, J. J. Janssens, S. M. Collins, and T. L. Peeters Region-specific antiproliferative effect of VIP and PACAP-(1---38) on rabbit enteric smooth muscle Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G303 - G310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Galligan Focus on: "G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor" Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1407 - C1408. [Full Text] [PDF]
|
|
|
|
|
|
K. S. Murthy, B.-Q. Teng, J.-G. Jin, and G. M. Makhlouf G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1409 - C1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-Q. Teng, K. S. Murthy, J. F. Kuemmerle, J. R. Grider, K. Sase, T. Michel, and G. M. Makhlouf Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, August 1, 1998; 275(2): G342 - G351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Sanders IV. Neural regulation of gastrointestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G1 - G7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Murthy and G. M. Makhlouf cGMP-mediated Ca2+ release from IP3-insensitive Ca2+ stores in smooth muscle Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1199 - C1205. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
